Plenary 3. Wed 02 June – talk 4, Thomas F. Lüscher
ASCVD management: will the future look smarter?: Thomas F. Lüscher, Zürich, Switzerland The rise of…
Young Investigator Awards for outstanding publications 2020
The winners of the annual Young Investigator Awards for outstanding publications during 2020 Basic Science…
Keynote Lecture
Professor Chris Packard: Triglyceride metabolism and its clinical implications Chris Packard is the R&D Director…
Plenary 3. Wed 02 June – talk 3, DeLisa Fairweather
Gender and Cardiovascular Disease: DeLisa Fairweather, Baltimore, USA The rise of cardiometabolic disease as global…
Plenary 3. Wed 02 June – talk 2, Miguel Martinez-Gonzalez
The Mediterranean diet, its components, and cardiovascular disease: Miguel Martinez-Gonzalez, Pamplona, Spain The rise of…
Plenary 3. Wed 02 June – Talk 1, Juleen R. Zierath
Exercise, inactivity, and circadian rhythms – re-setting the clock in metabolic disease: Juleen Zierath, Stockholm,…
Plenary 2. Tues 01 June – talk 3, Jean-Charles Fruchart
SPPARM alpha agonist for Nutrient and Energy Metabolism – Mechanisms and Therapeutic Opportunities: Jean-Charles Fruchart,…
Plenary 2. Tues 01 June – talk 2, Charalambos Antoniades
Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue? Charalambos Antoniades, Oxford,…
Plenary 2. Tues 01 June – talk 1, Mark Daly
From genetic discovery to clinical interventions to combat atherosclerosis: Mark Daly, Helsinki, Finland Future CVD…
Plenary 1. Mon 31 May – talk 4, Renu Virmani
Coronary artery calcification and its progression: what does it really mean? Renu Virmani, Baltimore, USA…
Plenary 1. Mon 31 May – talk 3, Esther Lutgens
The interface of immune and metabolic responses in atherosclerosis: Esther Lutgens, Amsterdam, The Netherlands Atherosclerosis:…
Plenary 1. Mon 31 May – talk 2, Jan Borén
Endothelial mechanotransduction, metabolism and lipoprotein transport in atherosclerosis: Jan Borén, Gothenburg, Sweden Atherosclerosis: metabolism dysfunction…
Plenary 1. Mon 31 May – talk 1, Gerard Pasterkamp
New phenotypes for stratification and modelling of atherosclerosis: Gerard Pasterkamp, Utrecht, The Netherlands Atherosclerosis: metabolism…
